Management of subglottic haemangioma.
Two contrasting methods of treatment for paediatric subglottic haemangioma are presented. Dr Hoeve describes his results using intralesional steroids and short-term intubation, and Dr Froehlich discusses his outcomes with open surgical excision. Mr Bailey then reviews the currently available therapeutic options with special reference to each of the above techniques, and suggests an optimum plan of management given our current state of knowledge. The conclusion is that very small haemangiomas may not require treatment, or may be amenable to CO2 laser vaporization. Medium-sized lesions seem suitable for intra-lesional steroids and intubation, but large ones are probably best managed by primary submucous resection. Very large haemangiomas, and especially those which are circumferential or in which magnetic resonance imaging (MRI) shows extension down into the trachea and/or through the tracheal wall into the surrounding tissues, may be more safely dealt with by performing a tracheostomy and awaiting spontaneous involution.
Bailey
C M
CM
Department of Otolaryngology, Great Ormond Street Hospital for Children, London, UK.
Froehlich
P
P
Hoeve
H L
HL
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D005260:Female; D018324:Hemangioma, Capillary / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D015552:Injections, Intralesional; D007442:Intubation, Intratracheal; D007822:Laryngeal Neoplasms / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D053685:Laser Therapy; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D018579:Patient Selection; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D008775:Methylprednisolone